Chrysalyne D. Schmults

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012

Pritesh S. Karia, Jiali Han, Chrysalyne D. Schmults · Journal of the American Academy of Dermatology · 2013 · 822 citations

Medicine, Pathology, Dermatology +6

Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma

Chrysalyne D. Schmults, Pritesh S. Karia, Joi B. Carter et al. · JAMA Dermatology · 2013 · 550 citations

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang et al. · The Lancet Oncology · 2020 · 457 citations · Full text

Single-arm Trial, Medicine, Pathology +5

Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma

Pritesh S. Karia, Anokhi Jambusaria‐Pahlajani, David P. Harrington et al. · Journal of Clinical Oncology · 2013 · 351 citations · Full text